tert-Butylhydroquinone structure
|
Common Name | tert-Butylhydroquinone | ||
---|---|---|---|---|
CAS Number | 1948-33-0 | Molecular Weight | 166.217 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 291.4±20.0 °C at 760 mmHg | |
Molecular Formula | C10H14O2 | Melting Point | 127-129 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 138.7±16.4 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of tert-ButylhydroquinoneTBHQ is an antioxidant that activates Nrf2. |
Name | 2-tert-butylhydroquinone |
---|---|
Synonym | More Synonyms |
Description | TBHQ is an antioxidant that activates Nrf2. |
---|---|
Related Catalog | |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 291.4±20.0 °C at 760 mmHg |
Melting Point | 127-129 °C(lit.) |
Molecular Formula | C10H14O2 |
Molecular Weight | 166.217 |
Flash Point | 138.7±16.4 °C |
Exact Mass | 166.099380 |
PSA | 40.46000 |
LogP | 2.33 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.545 |
Stability | Stable. Incompatible with strong bases, strong oxidizing agents. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn:Harmful |
Risk Phrases | R22 |
Safety Phrases | S26-S36-S28A |
RIDADR | UN3077 |
WGK Germany | 3 |
RTECS | MX4375000 |
Packaging Group | III |
Hazard Class | 9 |
HS Code | 29072900 |
Precursor 10 | |
---|---|
DownStream 9 | |
HS Code | 2907299090 |
---|---|
Summary | 2907299090 polyphenols; phenol-alcohols。supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward)。VAT:17.0%。tax rebate rate:9.0%。MFN tariff:5.5%。general tariff:30.0% |
Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells.
Br. J. Cancer 111(5) , 874-82, (2014) Standard therapy for acute promyelocytic leukaemia (APL) includes retinoic acid (all-trans retinoic acid (ATRA)), which promotes differentiation of promyelocytic blasts. Although co-administration of ... |
|
A method for long term stabilisation of long chain polyunsaturated fatty acids in dried blood spots and its clinical application.
Prostaglandins Leukot. Essent. Fatty Acids 91(6) , 251-60, (2014) Conventional assays of omega-3 long chain polyunsaturated fatty acid (n-3 LCPUFA) status in humans involve venous blood collection and expensive, multi-step processes that limit their usefulness as sc... |
|
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms.
Oncotarget 5(19) , 9118-32, (2014) Resistance to Imatinib mesylate (IM) is an emerging problem for patients with chronic myelogenous leukemia (CML). T315I mutation in the Bcr-Abl is the predominant mechanism of the acquired resistance ... |
Hydroquinone,tert-butyl |
1,4-Benzenediol, 2-(1,1-dimethylethyl)- |
2-(1,1-dimethylethyl)benzene-1,4-diol |
tert-Butylhydroquinone |
TBHQ |
2-tert-Butylhydroquinone |
Hydroquinone, t-butyl- |
2-tert-butyl-1,4-dihydroxybenzene |
2-(1,1-Dimethylethyl)-1,4-benzenediol |
Hydroquinone, tert-butyl- |
Butylhydroquinone, t- |
2-tert-Butyl-1,4-benzenediol |
tert-Butylhydroquinone (TBHQ) |
tert-butyl hydroquinone |
MFCD00002344 |
Butylhydroquinone, tert- |
EINECS 217-752-2 |
MTBHQ |
2-(2-Methyl-2-propanyl)-1,4-benzenediol |
t-Butyl hydroquinone |
2-tert-butyl-hydroquinone |
2-tert-Butylbenzene-1,4-diol |
Mono-tert-butylhydroquinone |
1-t-Butyl-1,4-dihydroxybenzene |
2-tertiary-butylhydroquinone |